The clinical-stage biotech could see its shares plummet should there be any clinical setback.

India’s underperformance this year is not about weak fundamentals, but about sentiment and missing foreign flows, said Harshal Dasani, Business Head at INVAsset PMS. FIIs sold Indian stocks worth ₹158 ...

Seville is all about astonishing architecture, from gothic and Mudejar (Muslim style, built for Christian rulers), to ...

Because kids love routines. I started a tradition of buying my daughter a journal-style planner every year around Christmas ...

Indonesia’s banking sector had a tough time in 2025 due to several challenges, mostly stemming from weaker domestic demand. A ...

This concept isn’t new—in fact, it is the essence of representational state transfer (REST). Instead of converting to a ...

For companies operating at the intersection of sustainability and supply-chain technology, financial structure is ...

As the Budget 2026 approaches, both taxpayers and financial professionals are already speculating about the impending changes ...

A team of researchers at Penn State have devised a new, streamlined approach to designing metasurfaces, a class of engineered ...

Will modern India see the rise of not one but two ideological parties, as happens in other democracies around the world?

With Karnataka opposing the compulsory Malayalam clause, a closer look at how the two neighbouring states structure their ...

Inter are assessing the future of Kristjan Asllani as interest grows from both Girona and Paris, with the midfielder ...